Mayne Pharma Group ( (AU:MYX) ) has shared an update.
Morgan Stanley and its subsidiaries have become substantial holders in Mayne Pharma Group Limited, acquiring a 5.03% voting power through various transactions. This development indicates a significant investment in Mayne Pharma, potentially impacting the company’s shareholder dynamics and market perception.
More about Mayne Pharma Group
YTD Price Performance: 53.47%
Average Trading Volume: 2,514
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $370.5M
Learn more about MYX stock on TipRanks’ Stock Analysis page.